Biofilm: Basic principles, pathophysiology, and implications for Clinicians

Surgical Infections

Volumn 15, Issue 1, 2014, Pages 1-7

  Hall, Michael R ^a   McGillicuddy, Edward ^a   Kaplan, Lewis J ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; N ACYLHOMOSERINE LACTONE;

ALIIVIBRIO FISCHERI; ANTIBIOTIC RESISTANCE; ARTIFICIAL VENTILATION; BACTERIUM ADHERENCE; BIOFILM; BIOFILM ASSOCIATED INFECTION; DEVICE INFECTION; ENDOTRACHEAL TUBE; ESCHERICHIA COLI; FOREIGN BODY; GASTROINTESTINAL INFECTION; HEMODIALYSIS; HUMAN; IMMUNE RESPONSE; INFECTION; INTERNAL FIXATOR; MEDICAL DEVICE; MICROBIAL COLONIZATION; MOUTH INFECTION; NONHUMAN; PACEMAKER; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS CATHETER; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; REVIEW; STAPHYLOCOCCUS AUREUS; SURGICAL TRAINING; TENSILE STRENGTH; TREATMENT DURATION; URINARY TRACT INFECTION; WOUND INFECTION;

BIOFILMS; CATHETER-RELATED INFECTIONS; CROSS INFECTION; ENVIRONMENTAL MICROBIOLOGY; HUMANS;

EID: 84893710765     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2012.129     Document Type: Review

References (65)

1. Costerton JW, Geesey GG, Cheng GK. How bacteria stick. Sci Am 1978;238:86-95.
2. Donlan RM, Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15:167-193.
3. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 1999;284: 1318-1322.
4. Donlan RM. Biofilms: Microbial life on surfaces. Emerg Infect Dis 2002;8:881-890.
5. NIH Research on Microbial Biofilms program announcement, release date 20 December 2002, http://grants.nih.gov/grants/guide/pa-files/PA-03-047.html.
6. Stoodley P, Sauer K, Davies DG, et al. Biofilms as complex differentiated communities. Annu Rev Microbiol 2002;56: 187-209.
7. Flemming HC, Neu TR, Wozniak DJ. The EPS matrix: the house of biofilm cells. J Bacteriol 2007;189:7945-7947.
8. Camilli A, Bassler BL. Bacterial small-molecule signaling pathways. Science 2006;311:1113-1116.
9. Lopez D, et al. Biofilms. Cold Spring Harb Perspect Biol 2010; doi 10.1101/cshperspect.a000398 originally published online June 2, 2010.
10. Hall-Stoodley L, Stoodley P, Kathiu S, et al. Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol 2012;65:127-145.
11. Costerton JW, Cheng K-J, Geesey GG, et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol 1987;41: 435-464.
12. Lawrence JR, Korber DR, Hoyle BD, Costerton JW. Optical sectioning of microbial biofilms. J Bacteriol 1991;173:6558-6567.
13. Stewart PS, Franklin MJ. Physiological heterogeneity in biofilms. Nat Rev Microbiol 2008;6:199-210.
14. Xu KD, Stewart PS, XIA F, et al. Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability. Appl Environ Microbiol 1998;64: 4035-4039.
15. Rani SA, Pitts B, Beyenal H, et al. Spatial patterns of DNA replication, protein synthesis, and oxygen concentration within bacterial biofilms reveal diverse physiological states. J Bacteriol 2007;189:4223-4233.
16. Renner LD, Weibel DB. Physicochemical regulation of biofilm formation. MRS Bull 2011;36:1-9; DOI:10.1557/mrs .2011.65
17. Singh AV, Vyas V, Patil R, et al. Quantitative characterization of the influence of the nanoscale morphology of nanostructured surfaces on bacterial adhesion and biofilm formation. PloS One 2011;6:e25029. doi:10.1371/journal. pone.0025029
18. Costerton JW. The etiology and persistence of cryptic bacterial infections; a hypothesis. Rev Infect Dis 1984;6 Suppl 3:5608-5616.
19. Bester E, Kroukamp O, Wolfaardt GM, et al. Metabolic differentiation in biofilms as indicated by carbon dioxide production rates. Appl Environ Microbiol 2010;76:1189-1197.
20. Engebrecht J, Nalson K, Silverman M. Bacterial bioluminescence: Isolation and genetic analysis of functions from Vibrio fischeri. Cell 1983;32:773-781.
21. Eberhard A, Burlingame AL, Eberhard C, et al. Structural identification of autoinducer of Photobacterium fischeri luciferase. Biochemistry 1981;20;2444-2449.
22. Fuqua WC, Winans SC, Greenberg EP. Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. J Bacteriol 1994;176:269-275.
23. Fuqua C, Greenberg EP. Listening in on bacteria: Acylhomoserine lactone signaling. Nat Rev Mol Cell Bio 2002;3: 685-695.
24. Antunes LC, Ferreira RB. Intercellular communication in bacteria. Crit Rev Microbiol 2009;35:69-80.
25. Vendeville A, Winzer K, Heurlier K, et al. Making sense of metabolism: autoinducer-2, LuxS and pathogenic bacteria. Nat Rev Microbiol 2005;3:383-396.
26. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: From the natural environment to infectious disease. Nat Rev Microbiol 2004;2:95-108.
27. Li Y, Tian X. Quorum sensing and bacterial social interactions in biofilms. Sensors 2012;12:2519-2538.
28. Davies DG, Parsek MR, Pearson JP, et al. The involvement of cell-to-cell signals in the development of bacterial biofilm. Science 1998;280,295-298.
29. Lopez D, Kolter R. Extracellular signals that define distinct and coexisting cell fates in Bacillus subtilis. FEMS Microbiol Rev 2009;34:134-149.
30. Hall-Stoodley L, Stoodley P, Kathju S, et al. Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol 2012;1-19.
31. NIH Research on Microbial Biofilms program announcement, release date 20 December 2002, http://grants.nih.gov/grants/guide/pa-files/PA-03-047.html
32. James GA, Swogger E, Pulcini Ed, et al. Biofilms in chronic wounds. Wound Repair Regen 2008;16:37-44.
33. Fazli M, Bjamsholt T, Kirketerp-Moller K, et al. Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J Clin Microbiol 2009;47:4084-4089.
34. Wolcott RD, Kennedy JP, Dowd SE. Regular debridement is the main tool for maintaining a healthy wound bed in most chronic wounds. J Wound Care 2009;18:54-56.
35. Seymour GJ, Ford PJ, Cullinan MP, et al. Relationship between periodontal infections and systemic disease. Clin Microbiol Infect 2007;13(Suppl 4):3-10.
36. Wagner VE, Iglewski BH. P. aeruginosa biofilms in CF infection. Clin Rev Allergy Immunol 2008;35:124-134.
37. Genuit T, Bochicchio G, Napolitano LM, et al. Prophylactic chlorhexidine oral rinse decreases ventilator-associated pneumonia in surgical ICU patients. Surg Infect 2001;2:5-18.
38. Scannapieco FA, Yu J, Raghavendran K, et al. A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients. Crit Care 2009; 13:R117.
39. Kollef MH, Afessa B, Anzueto A, et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: The NASCENT randomized trial. JAMA 2008;300: 805-813.
40. Cole SP, Harwood J, Lee R, et al. Characterization of monospecies biofilm formation by Helicobacter pylori. J Bacteriol 2004;186:3124-3132.
41. Cammarota G, Branca G, Ardito F, et al. Biofilm demolition and antibiotic treatment to eradicate resistent Helicobacter pylori: A clinical trial. Clin GastroenterolHepatol 2010;8:817-820.
42. Crawford RW, Rosales-Reyes R, Ramirez-Aguilar Mde L, et al. Gallstones play a significant role in Salmonella spp. gallbladder colonization and carriage. Proc Natl Acad Sci USA 2010;107:4353-4358.
43. Macfarlane S. Microbial biofilm communities in the gastrointestinal tract. J Clin Gastroenterol 2008; 42(Suppl 3, Pt 1): S142-143.
44. Frank DN, Wilson SS, St Amand AL, et al. Cultureindependent microbiological analysis of foley urinary catheter biofilms. PLoS One 2009;4:e7811.
45. Wang X, Lunsdorf H, Ehren I, et al. Characteristics of biofilms from urinary tract catheters and presence of biofilmrelated components in Escherichia coli. Curr Microbiol 2010;60:446-453.
46. Blango MG, Mulvey MA. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 2010;54:1855-1863.
47. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001;32:1249-1272.
48. Alberti C, Brun-Buisson C, Burchardi H, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intens Care Med 2002;28:108-121.
49. Donelli, G. Vascular catheter-related infection and sepsis. Surg Infect 2006;7(Suppl 2):25-27.
50. Lewis K. Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol 2008;322:107-131.
51. Stewart PS, Davison WM, Steenbergen JN, et al. Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm. Antimicrob Agents 2009;53:3505-3507.
52. Stewart PS, Franklin MJ. Physiological heterogeneity in biofilms. Nat Rev Microbiol 2008;6:199-210.
53. Bagge N, Schuster M, Hentzer M, et al. Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. Antimicrob Agents Chemother 2004;48:1175-1187.
54. Beaudoin D, Bryers JD, Cunningham AB, et al. Mobilization of broad host range plasmid from Pseudomonas putida to established biofilm of Bacillus azotoformans. Biotechnol Bioeng 1998;57:272-279.
55. Borriello G, Werner E, Roe F, et al. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother 2004;48:2659-2664.
56. Lewis K. Persister cells and the riddle of biofilm survival. Biochemistry (Mosc) 2005;70:267-274.
57. Fux CA, Costerton JW, Stewart PS, et al. Survival strategies of infectious biofilms. Trends Microbiol 2005;13:34-40.
58. Hoffman LR, DArgenio DA, MacCoss MJ, et al. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 2005;436:1171-1175.
59. NIH Research on Microbial Biofilms program announcement, release date 20 December 2002, http://grants.nih.gov/grants/guide/pa-files/PA-03-047.html
60. Leid JG, Shirtliff ME, Costerton JW, et al. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun 2002;70:6339-6345.
61. Jesaitis AJ, Franklin MJ, Berglund D, et al. Compromised host defense on Pseudomonas aeruginosa biofilms: Characterization of neutrophil and biofilm interactions. J Immunol 2003;171:4329-4339.
62. Walker TS, Tomlin KL, Worthen GS, et al. Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect Immun 2005;73:3693-3701.
63. Brackman G, Cos P, Maes L, et al. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob Agents Chemother 2011;55: 2655-2661.
64. Kolodkin-Gal I, Romero D, Cao S, et al. D-amino acids trigger biofilm disassembly. Science 2010;328:627-629; published online April 29, 2010; doi:10.1126/science.1188628
65. SCORE Curriculum outline. www.surgicalcore.org/curriculu moutline2011-12.pdf; accessed June 21, 2012.